Advertisement

Supportive Care in Cancer

, Volume 28, Issue 2, pp 617–624 | Cite as

Ethical considerations in screening head and neck cancer patients for psychosocial distress

  • Julie M. DeleemansEmail author
  • Kerry Mothersill
  • Barry D. Bultz
  • Fiona Schulte
Original Article

Abstract

Rationale

Head and neck cancer (HNC) patients and survivors are a particularly vulnerable group with disproportionately high levels of psychosocial distress. Untreated psychosocial distress among HNC patients has consistently been associated with poorer health and psychosocial outcomes. Screening for distress (SFD) allows health care providers to identify and monitor patient’s distress, and when needed, to subsequently provide appropriate psychosocial supports that aim to reduce suffering and improve patients’ overall well-being. However, despite mounting evidence for the benefits of SFD some oncology centers continue to neglect SFD in HNC patients and survivors, thereby depriving these patients of the opportunity to have their unmet psychosocial needs appropriately addressed. The present paper reviews SFD literature and explores ethical considerations in screening HNC patients and for distress.

Conclusions

Screening HNC patients for distress and facilitating the alleviation of suffering are important steps in providing ethical care. HNC oncology administrators, surgical departments, and clinicians are urged to consider the implementation of SFD for HNC patients and to take the necessary steps in implementing SFD practices and psychosocial care.

Keywords

Head Neck Psychosocial Distress Ethic 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Accreditation Report (2016) 3 edn. Accreditation Canada, Edmonton, AlbertaGoogle Scholar
  2. 2.
    Bultz BD, Groff SL, Fitch M, Blais MC, Howes J, Levy K, Mayer C (2011) Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 20(5):463–469.  https://doi.org/10.1002/pon.1932 CrossRefPubMedGoogle Scholar
  3. 3.
    Feldstain A, Tomei C, Belanger M, Lebel S (2014) Screening for distress in patients with cancer: methodologic considerations. Curr Oncol 21(2):e330–e333.  https://doi.org/10.3747/co.21.1794 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Council NP (2001) Pain: current understanding of assessment, management and treatments. 29Google Scholar
  5. 5.
    Engel GL (1980) The clinical application of the biopsychosocial model. Am J Psychiatry 137(5):535–544.  https://doi.org/10.1176/ajp.137.5.535 CrossRefPubMedGoogle Scholar
  6. 6.
    Bultz BD, Carlson LE (2006) Emotional distress: the sixth vital sign--future directions in cancer care. Psychooncology 15(2):93–95.  https://doi.org/10.1002/pon.1022 CrossRefPubMedGoogle Scholar
  7. 7.
    Holland JC, Bultz BD (2007) The NCCN guideline for distress management: case for making distress the 6th vital sign. J Natl Compr Cancer Netw 5(1):3–7CrossRefGoogle Scholar
  8. 8.
    Network NCC (1999; 2014) NCCN clinical practice guidelines in oncology (NCCN guidelines): Distress management. https://www.nccn.org/professionals/physician_gls/default.aspx#supportive Accessed 1 Apr 2018
  9. 9.
    Carlson LE, Groff SL, Maciejewski O, Bultz BD (2010) Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 28(33):4884–4891.  https://doi.org/10.1200/JCO.2009.27.3698 CrossRefPubMedGoogle Scholar
  10. 10.
    Carlson LE, Waller A, Mitchell AJ (2012) Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 30(11):1160–1177.  https://doi.org/10.1200/JCO.2011.39.5509 CrossRefPubMedGoogle Scholar
  11. 11.
    Carlson LE, Bultz BD (2004) Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 13(12):837–849; discussion 850-836.  https://doi.org/10.1002/pon.832 CrossRefPubMedGoogle Scholar
  12. 12.
    Institute NC (2018) Head and neck cancers. https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet. Accessed 1 Apr 2018
  13. 13.
    Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86(2):104–114.  https://doi.org/10.1177/154405910708600202 CrossRefPubMedGoogle Scholar
  14. 14.
    Stoyanov GS, Kitanova M, Dzhenkov DL, Ghenev P, Sapundzhiev N (2017) Demographics of head and neck cancer patients: a single institution experience. Cureus 9(7):e1418.  https://doi.org/10.7759/cureus.1418 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rettig EM, D’Souza G (2015) Epidemiology of head and neck cancer. Surg Oncol Clin N Am 24(3):379–396.  https://doi.org/10.1016/j.soc.2015.03.001 CrossRefPubMedGoogle Scholar
  16. 16.
    Simard EP, Torre LA, Jemal A (2014) International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 50(5):387–403.  https://doi.org/10.1016/j.oraloncology.2014.01.016 CrossRefPubMedGoogle Scholar
  17. 17.
    Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, Forouzanfar T (2017) Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer 82:115–127.  https://doi.org/10.1016/j.ejca.2017.05.026 CrossRefPubMedGoogle Scholar
  18. 18.
    Howren MB, Christensen AJ, Karnell LH, Funk GF (2013) Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol 81(2):299–317.  https://doi.org/10.1037/a0029940 CrossRefPubMedGoogle Scholar
  19. 19.
    Sterba KR, Zapka J, LaPelle N, Garris TK, Buchanan A, Scallion M, Day T (2017) Development of a survivorship needs assessment planning tool for head and neck cancer survivors and their caregivers: a preliminary study. J Cancer Surviv 11(6):822–832.  https://doi.org/10.1007/s11764-017-0621-4 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Björklund M, Sarvimäki A, Berg A (2010) Living with head and neck cancer: a profile of captivity. J Nurs Healthc Chronic Illn 2(1):22–31.  https://doi.org/10.1111/j.1752-9824.2010.01042.x CrossRefGoogle Scholar
  21. 21.
    Ghazali N, Roe B, Lowe D, Tandon S, Jones T, Shaw R, Risk J, Rogers SN (2017) Using the patients concerns inventory for distress screening in post-treatment head and neck cancer survivors. J Craniomaxillofac Surg 45(10):1743–1748.  https://doi.org/10.1016/j.jcms.2017.07.009 CrossRefPubMedGoogle Scholar
  22. 22.
    Kam D, Salib A, Gorgy G, Patel TD, Carniol ET, Eloy JA, Baredes S, Park RC (2015) Incidence of suicide in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 141(12):1075–1081.  https://doi.org/10.1001/jamaoto.2015.2480 CrossRefPubMedGoogle Scholar
  23. 23.
    Osazuwa-Peters N, Simpson MC, Zhao L, Boakye EA, Olomukoro SI, Deshields T, Loux TM, Varvares MA, Schootman M (2018) Suicide risk among cancer survivors: head and neck versus other cancers. Cancer 124(20):4072–4079.  https://doi.org/10.1002/cncr.31675 CrossRefPubMedGoogle Scholar
  24. 24.
    Kim SA, Roh JL, Lee SA, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY (2016) Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer 122(1):131–140.  https://doi.org/10.1002/cncr.29693 CrossRefPubMedGoogle Scholar
  25. 25.
    Bultz BD, Waller A, Cullum J, Jones P, Halland J, Groff SL, Leckie C, Shirt L, Blanchard S, Lau H, Easaw J, Fassbender K, Carlson LE (2013) Implementing routine screening for distress, the sixth vital sign, for patients with head and neck and neurologic cancers. J Natl Compr Cancer Netw 11(10):1249–1261CrossRefGoogle Scholar
  26. 26.
    Krebber AM, Jansen F, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM (2016) Screening for psychological distress in follow-up care to identify head and neck cancer patients with untreated distress. Support Care Cancer 24(6):2541–2548.  https://doi.org/10.1007/s00520-015-3053-6 CrossRefPubMedGoogle Scholar
  27. 27.
    Chen AM, Hsu S, Felix C, Garst J, Yoshizaki T (2018) Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation. Laryngoscope 128(3):641–645.  https://doi.org/10.1002/lary.26751 CrossRefPubMedGoogle Scholar
  28. 28.
    Dunne S, Mooney O, Coffey L, Sharp L, Desmond D, Timon C, O'Sullivan E, Gallagher P (2017) Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015. Psychooncology 26(2):149–160.  https://doi.org/10.1002/pon.4109 CrossRefPubMedGoogle Scholar
  29. 29.
    Smith JD, Shuman AG, Riba MB (2017) Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions. Curr Psychiatry Rep 19(9):56.  https://doi.org/10.1007/s11920-017-0811-9 CrossRefPubMedGoogle Scholar
  30. 30.
    Henry M, Rosberger Z, Bertrand L, Klassen C, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Black M, MacDonald C, Zhang X, Chartier G, Frenkiel S (2018) Prevalence and risk factors of suicidal ideation among patients with head and neck cancer: longitudinal study. Otolaryngol Head Neck Surg 159(5):843–852.  https://doi.org/10.1177/0194599818776873 CrossRefPubMedGoogle Scholar
  31. 31.
    Hellstadius Y, Lagergren J, Zylstra J, Gossage J, Davies A, Hultman CM, Lagergren P, Wikman A (2017) A longitudinal assessment of psychological distress after oesophageal cancer surgery. Acta Oncol 56(5):746–752.  https://doi.org/10.1080/0284186X.2017.1287945 CrossRefPubMedGoogle Scholar
  32. 32.
    Melinda Smith JS, Segal J (2018) Depression symptoms and warning signs. HelpGuide.org. https://www.helpguide.org/articles/depression/depression-symptoms-and-warning-signs.htm. Accessed March 2018
  33. 33.
    Williams C (2017) Psychosocial distress and distress screening in multidisciplinary head and neck cancer treatment. Otolaryngol Clin N Am 50(4):807–823.  https://doi.org/10.1016/j.otc.2017.04.002 CrossRefGoogle Scholar
  34. 34.
    Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, Eerenstein SEJ, van Weert S, de Bree R, Leemans CR, Verdonck-de Leeuw IM (2017) Durable usage of patient-reported outcome measures in clinical practice to monitor health-related quality of life in head and neck cancer patients. Support Care Cancer 25(12):3775–3783.  https://doi.org/10.1007/s00520-017-3808-3 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Cohen A, Ianovski LE, Frenkiel S, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Black M, MacDonald C, Chartier G, Rosberger Z, Henry M (2018) Barriers to psychosocial oncology service utilization in patients newly diagnosed with head and neck cancer. Psychooncology 27(12):2786–2793.  https://doi.org/10.1002/pon.4889 CrossRefPubMedGoogle Scholar
  36. 36.
    Fang CY, Heckman CJ (2016) Informational and support needs of patients with head and neck cancer: current status and emerging issues. Cancers Head Neck 1.  https://doi.org/10.1186/s41199-016-0017-6
  37. 37.
    Association CM (2004) CMA Code of EthicsGoogle Scholar
  38. 38.
    Association AM (2001) AMA code of medical ethics. AMA principles of medical ethics. American Medical AssociationGoogle Scholar
  39. 39.
    Association CP (2017) Canadian code of ethics for psychologists 4th edition. OttawaGoogle Scholar
  40. 40.
    Osazuwa-Peters N, Simpson MC, Zhao L (2018) Suicide risk among cancer survivors: head and neck versus other cancers. Paper presented at the 2018 Cancer Survivorship SymposiumGoogle Scholar
  41. 41.
    Havelka M, Lucanin JD, Lucanin D (2009) Biopsychosocial model--the integrated approach to health and disease. Coll Antropol 33(1):303–310PubMedGoogle Scholar
  42. 42.
    Pirl WF, Fann JR, Greer JA, Braun I, Deshields T, Fulcher C, Harvey E, Holland J, Kennedy V, Lazenby M, Wagner L, Underhill M, Walker DK, Zabora J, Zebrack B, Bardwell WA (2014) Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer 120(19):2946–2954.  https://doi.org/10.1002/cncr.28750 CrossRefPubMedGoogle Scholar
  43. 43.
    Tanguay-Gordon J, Gregan J, Nault C, Ladouceur B, Boonstra M, Andrews C, Kachuik L (2017) Development of an interprofessional education class to support patients with head and neck cancerGoogle Scholar
  44. 44.
    van der Meulen IC, May AM, de Leeuw JR, Koole R, Oosterom M, Hordijk GJ, Ros WJ (2014) Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer 110(3):593–601.  https://doi.org/10.1038/bjc.2013.733 CrossRefGoogle Scholar
  45. 45.
    Zernicke KA, Campbell TS, Speca M, Mccabe-Ruff K, Flowers S, Carlson LE (2014) A randomized wait-list controlled trial of feasibility and efficacy of an online mindfulness–based cancer recovery program. Psychosom Med 76(4):257–267.  https://doi.org/10.1097/psy.0000000000000053 CrossRefPubMedGoogle Scholar
  46. 46.
    Cancer Co (2016) Cancer program standards https://www.facs.org/quality-programs/cancer/coc/standards. Accessed Aug 2018

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Julie M. Deleemans
    • 1
    • 2
    • 3
    Email author
  • Kerry Mothersill
    • 4
  • Barry D. Bultz
    • 2
    • 5
  • Fiona Schulte
    • 1
    • 2
    • 4
  1. 1.Division of Medical Science, Cumming School of MedicineUniversity of CalgaryCalgaryCanada
  2. 2.Division of Psychosocial Oncology, Department of Oncology, Cumming School of MedicineUniversity of CalgaryCalgaryCanada
  3. 3.Psychosocial Oncology DepartmentHoly Cross HospitalCalgaryCanada
  4. 4.Department of Psychology, Faculty of ArtsUniversity of CalgaryCalgaryCanada
  5. 5.Department of Psychiatry, Cumming School of MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations